Total Payments
$9,731
2024 Payments
$560.69
Companies
34
Transactions
388
Medicare Patients
1,162
Medicare Billing
$146,426
Payment Breakdown by Category
Food & Beverage$9,731 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,731 | 388 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,512 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,095 | 33 | $0 (2021) |
| PFIZER INC. | $1,057 | 38 | $0 (2024) |
| Novo Nordisk Inc | $880.96 | 48 | $0 (2024) |
| Lilly USA, LLC | $801.66 | 19 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $753.32 | 32 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $527.67 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $476.74 | 22 | $0 (2022) |
| GlaxoSmithKline, LLC. | $332.53 | 23 | $0 (2024) |
| Amgen Inc. | $320.61 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.69 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($202.70) |
| 2023 | $724.97 | 29 | Novo Nordisk Inc ($156.34) |
| 2022 | $998.31 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($259.15) |
| 2021 | $1,669 | 72 | SANOFI-AVENTIS U.S. LLC ($361.62) |
| 2020 | $483.30 | 26 | AstraZeneca Pharmaceuticals LP ($94.23) |
| 2019 | $1,013 | 47 | AstraZeneca Pharmaceuticals LP ($317.57) |
| 2018 | $1,723 | 67 | AstraZeneca Pharmaceuticals LP ($328.47) |
| 2017 | $2,560 | 77 | Lilly USA, LLC ($575.11) |
All Payment Transactions
388 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Oncology | ||||||
| 07/16/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiology | ||||||
| 05/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: DIABETES | ||||||
| 05/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: DIABETES | ||||||
| 03/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: DIABETES | ||||||
| 01/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Diabetes | ||||||
| 01/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 268 | 433 | $74,165 | $35,778 |
| 2022 | 3 | 198 | 382 | $75,916 | $33,492 |
| 2021 | 3 | 235 | 422 | $83,144 | $39,974 |
| 2020 | 10 | 461 | 581 | $94,483 | $37,181 |
Total Patients
1,162
Total Services
1,818
Medicare Billing
$146,426
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 252 | $53,136 | $21,876 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $11,900 | $8,927 | 75.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 40 | $5,479 | $2,621 | 47.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 30 | 30 | $1,500 | $1,005 | 67.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $1,450 | $909.73 | 62.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $700.00 | $439.18 | 62.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 281 | $59,255 | $21,934 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 75 | 75 | $13,125 | $10,099 | 76.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 26 | $3,536 | $1,459 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 296 | $62,420 | $25,145 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 92 | 92 | $16,100 | $12,690 | 78.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 34 | $4,624 | $2,138 | 46.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 119 | 226 | $47,686 | $14,706 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 95 | 95 | $16,625 | $11,515 | 69.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 23 | 23 | $6,075 | $5,163 | 85.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 52 | $7,072 | $2,082 | 29.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 16 | 16 | $2,750 | $1,895 | 68.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 40 | 40 | $1,660 | $702.05 | 42.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 46 | 49 | $8,825 | $388.49 | 4.4% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 12 | 12 | $600.00 | $350.76 | 58.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $340.00 | $193.93 | 57.0% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 57 | 57 | $2,850 | $185.60 | 6.5% |
About Dr. Rajeev Gupta, MD
Dr. Rajeev Gupta, MD is a Internal Medicine healthcare provider based in Cumberland, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659358836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajeev Gupta, MD has received a total of $9,731 in payments from pharmaceutical and medical device companies, with $560.69 received in 2024. These payments were reported across 388 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($9,731).
As a Medicare-enrolled provider, Gupta has provided services to 1,162 Medicare beneficiaries, totaling 1,818 services with total Medicare billing of $146,426. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cumberland, RI
- Active Since 12/28/2005
- Last Updated 07/31/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659358836
Products in Payments
- JARDIANCE (Drug) $1,295
- FARXIGA (Drug) $767.13
- ELIQUIS (Drug) $736.47
- Ozempic (Drug) $579.26
- TRULICITY (Drug) $508.71
- XARELTO (Drug) $476.74
- ENTRESTO (Drug) $399.43
- LYRICA (Drug) $270.17
- TOUJEO (Drug) $195.66
- SOLIQUA 100/33 (Biological) $193.47
- Rybelsus (Drug) $181.01
- TOUJEO (Biological) $168.66
- TRELEGY ELLIPTA (Drug) $168.23
- Livalo (Drug) $161.53
- SYMBICORT (Drug) $155.98
- SPIRIVA RESPIMAT (Drug) $138.08
- Prolia (Biological) $130.70
- LEQVIO (Drug) $128.24
- JANUVIA (Drug) $126.52
- DALIRESP (Drug) $124.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cumberland
Amit Sachdev, M.d, M.D
Internal Medicine — Payments: $53,829
Internal Medicine $53,829
Dr. Scott Wilson, M.d, M.D
Internal Medicine — Payments: $22,426
Internal Medicine $22,426
Dr. Huma Shakil, M.d, M.D
Internal Medicine — Payments: $7,151
Internal Medicine $7,151
Sheba Asghar, M.d, M.D
Internal Medicine — Payments: $5,699
Internal Medicine $5,699
Dr. Christopher Haas, D.o, D.O
Internal Medicine — Payments: $4,867
Internal Medicine $4,867
Sunil Gupta, Md, MD
Internal Medicine — Payments: $4,082
Internal Medicine $4,082